[ Building ] Capacity
[ Building Capactiy ]
Strengthening research capacity enables individuals and institutions to be responsive to regional health priorities and participate in the global research agenda.
Our 125 Campaign directs comprehensive investment towards the whole research ecosystem. A cornerstone of this vision is the joint appointment of Global Leaders and Fellowships, fully affiliated to LSTM and based at partner institutions, with tailored institutional support based on international best practice (such as grant, HR and project management expertise). Our virtual health incubator, HIVE (Health Innovation in a Virtual Environment), connects researchers and clinicians with entrepreneurs, industry and advisors to create existing new ideas for health. Our unique Clinical Trials Management Training Programme provides secondments and mentorship to advance global clinical trials capabilities, including human challenge models pioneered at LSTM.
Related news
HiVE
HiVE is LSTM’s pioneering virtual incubator, which aims to identify and test new ideas for global health by bringing together virtual teams across borders, sectors, and disciplines.
We know from working in the field across the world that there is no shortage of talented and motivated individuals who are driven to make a difference in their communities, countries and beyond. There is, however, a shortage of opportunities for these individuals to reach their full potential; we believe the HIVE could be the key to unlocking it.
Why your support is so important?
Support from donors enables us to push the boundaries of traditional research and statutory funding. They allow the freedom to develop solutions which will catalyse new knowledge and research funding, ultimately decreasing reliance on aid.
Donations enable us to invest in new, untested, and perhaps unconventional ideas and the most promising students and scientists. These are the people who will lead the world in finding solutions to humanity biggest health challenges.
Donations allow the flexibility to work with new partners and support them in developing their own research infrastructure and competitiveness. This creates collaborations which are responsive to regional challenges, but which have the potential to benefit human health worldwide.
